GLC determination of tilidine, nortilidine, and bisnortilidine in biological fluids with a nitrogen-sensitive detector.
A sensitive and specific GLC method is described to determine therapeutic levels of tilidine and its two main metabolites, nortilidine and bisnortilidine, in plasma and urine. The method involves the extraction of the compounds and an internal standard with cyclohexane from alkalinized samples, followed by back-extraction into 1 N HCl. The hydrochloric acid solution is evaporated to dryness. After liberation of the free bases with ammonia, the residue is subjected to GLC analysis with a nitrogen-phosphorus detector and a 1.8-m (6-ft) glass column packed with 1% CRS 101 and 1.5% LAC-4-R-886 on Gas Chrom Q. Sensitivity in plasma and urine is approximately 1 ng/ml for a 5-ml sample.
D000328:Adult; D002849:Chromatography, Gas; D003509:Cyclohexanecarboxylic Acids / Q000032:analysis*; D003640:Dealkylation; D006801:Humans; D008297:Male; D008722:Methods; D013993:Tilidine / Q000032:analysis* / Q000097:blood / Q000652:urine
D003509:Cyclohexanecarboxylic Acids; D013993:Tilidine